Top 20 Companies in Angioplasty Balloons Stents Market 2025: Strategic Overview and Future Trends (2024–2035)

Description

According to a research report published by Spherical Insights & Consulting, The Global Angioplasty Balloons Stents Market Size Is Projected To Grow From USD 2.94 Billion In 2024 To USD 4.41 Billion By 2035, At A CAGR Of 3.75% During The Forecast Period 2024–2035. The global angioplasty balloons stents market is being driven by the increasing number of people with cardiovascular diseases (CVDs), the rise in demand for minimally invasive procedures, growing innovations in drug-coated/drug-eluting balloons, and others

 

Introduction

The angioplasty balloons stents market refers to the global industry involved in the development, manufacturing, and distribution of medical devices used in minimally invasive procedures to treat narrowed or blocked blood vessels, particularly in cardiovascular diseases. Angioplasty serves as a treatment method that physicians use to restore blood circulation through obstructed arteries, which commonly occur in patients with coronary artery disease. The procedure uses a tiny balloon to expand obstructed arteries before medical professionals insert a stent to maintain artery openness.

 

Boston Scientific Corporation has introduced the Sterling SL PTA Balloon Dilatation Catheter to the United States and European markets. This high-performance balloon dilatation catheter has been created for use in peripheral angioplasty procedures, which target blood vessels below the knee. Gore & Associates, Inc. announced that the FDA approved a lower-profile Viabahn VBX balloon expandable endoprosthesis for treating complex vascular disease.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Angioplasty Balloons Stents Market.

 

Segment Insights: Key Segments Shaping Market Growth

Global Angioplasty Balloons Stents Market Size, Share, By Product (Stents, Balloons), Indication (Coronary Artery Diseases, Peripheral Artery Diseases), End-User (Hospitals, Ambulatory Surgical Centers, Cath Labs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

 

Angioplasty Balloons Stents Market Size & Statistics

• The Market Size for Angioplasty Balloons Stents Was Estimated to be worth USD 2.94 Billion in 2024.
• The Market is Going to Expand at a CAGR of 3.75% between 2024 and 2035.
• The Global Angioplasty Balloons Stents Market Size is anticipated to reach USD 4.41 Billion by 2035.
• North America is expected to generate the highest demand during the forecast period in the Angioplasty Balloons Stents Market
• Asia Pacific is expected to grow the fastest during the forecast period in the Angioplasty Balloons Stents Market.

Regional growth and demand

Asia Pacific is expected to grow the fastest during the forecast period in the Angioplasty Balloons Stents market. Asia Pacific is projected to grow fastest due to a sizable senior population that is more susceptible to cardiovascular diseases. Japan has one of the largest numbers of aged people in the world, while China and India are seeing substantial rises in their aging populations. This generational shift raises the incidence of coronary and peripheral arterial disorders.

 

North America is expected to generate the highest demand during the forecast period in the Angioplasty Balloons Stents market. North America is expected to generate the highest demand due to the increasing application of angioplasty balloons and stents in the treatment and management of peripheral and coronary artery disease, which are on the rise in the region, increasing sedentary lifestyle, anxiety, and stress resulting in chronic diseases, such as diabetes and obesity, leading to an increase in the prevalence of multiple cardiovascular diseases.

 

 

Top 10 Trends in the Angioplasty Balloons Stents Market

• Rising Preference for Minimally Invasive Procedures
• Growing Adoption of Drug-Eluting Stents (DES)
• Emergence of Bioresorbable Stents
• Advancements in Drug-Coated Balloons
• Integration of AI and Digital Technologies
• Growth of Robotic-Assisted Angioplasty
• Development of Advanced Materials and Coatings
• Increasing Demand from Emerging Markets
• Expansion of Outpatient and Ambulatory Procedures
• Continuous Product Innovation and R&D Investments

 

• Rising Preference for Minimally Invasive Procedures

The market is the growing shift toward minimally invasive procedures such as angioplasty instead of open-heart surgeries. These procedures use catheters, balloons, and stents to treat blocked arteries with smaller incisions, less pain, and faster recovery times. Patients and healthcare providers increasingly prefer these techniques because they reduce hospital stays, lower complication risks, and improve overall patient outcomes.

 

• Growing Adoption of Drug-Eluting Stents (DES)

Drug-eluting stents (DES) are becoming the standard of care in many angioplasty procedures due to their ability to release medication directly into the artery wall, preventing re-narrowing. Compared to traditional bare-metal stents, DES significantly improve long-term outcomes by reducing the need for repeat procedures. Continuous innovation in drug formulations and coating technologies has further enhanced their effectiveness and safety.

 

• Emergence of Bioresorbable Stents

Bioresorbable stents (also called bioresorbable scaffolds) represent a major technological advancement. Unlike permanent metallic stents, these devices gradually dissolve in the body after restoring blood flow, allowing the artery to return to its natural state. This innovation helps reduce long-term complications such as chronic inflammation, late thrombosis, and restrictions on future surgical procedures.

 

• Advancements in Drug-Coated Balloons

Drug-coated balloons (DCBs) are transforming angioplasty by offering a “leave nothing behind” approach. These balloons deliver anti-proliferative drugs directly to the artery during inflation, eliminating the need for a permanent implant. They are particularly effective in treating conditions like in-stent restenosis and small vessel disease.

 

• Integration of AI and Digital Technologies

Artificial intelligence (AI) and digital technologies are reshaping angioplasty procedures by improving diagnostic accuracy, treatment planning, and procedural precision. AI-powered tools can analyze medical imaging to identify blockages, assess severity, and recommend optimal treatment strategies

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the angioplasty balloons stents market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Angioplasty Balloons Stents Market.

 

 

Top 20 Companies Leading the Angioplasty Balloons Stents Market

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic plc
• Terumo Corporation
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• Lepu Medical Technology Co., Ltd.
• Cook Medical
• Meril Life Sciences Pvt. Ltd.
• Cardinal Health, Inc.
• C. R. Bard, Inc.
• Alvimedica
• Hexacath
• Concept Medical Inc.
• Translumina Therapeutics LLP
• Sahajanand Medical Technologies Pvt. Ltd.
• Amaranth Medical
• REVA Medical, Inc.
• OrbusNeich Medical Company Limited

 

• Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA

Abbott is a global healthcare leader with a strong presence in cardiovascular devices, diagnostics, and medical technologies. The company plays a major role in the angioplasty market through its advanced portfolio of stents, catheters, and vascular devices. Abbott’s cardiovascular segment includes products such as drug-eluting stents, vascular scaffolds, and structural heart solutions. Its innovations focus on improving patient outcomes through minimally invasive treatments. The company operates in over 160 countries and generates a significant portion of its revenue from medical devices, highlighting its strong market position.

 

• Boston Scientific Corporation

Headquarters: Marlborough, Massachusetts, USA

Boston Scientific is a leading developer of medical devices used in interventional cardiology and peripheral vascular procedures. The company specializes in technologies for angioplasty, including balloons, stents, and catheter-based delivery systems. Its product portfolio spans multiple therapeutic areas such as cardiovascular, endoscopy, urology, and neuromodulation. The company is known for its strong focus on innovation and minimally invasive technologies, which are critical in angioplasty procedures. Boston Scientific continues to grow through strategic acquisitions and product development, strengthening its position in global cardiovascular markets.

 

• Medtronic plc

Headquarters: Dublin, Ireland

Medtronic is one of the world’s largest medical technology companies, with a strong presence in cardiovascular and vascular intervention markets. The company develops advanced solutions, including stents, balloons, and cardiac rhythm devices. Medtronic focuses heavily on minimally invasive therapies, helping treat millions of patients annually across more than 150 countries. Its innovations in cardiac care, such as advanced ablation systems and integrated digital technologies, position it as a leader in interventional procedures. The company’s global reach, strong R&D investments, and focus on next-generation technologies make it a dominant force in the angioplasty segment.

 

• Terumo Corporation

Headquarters: Tokyo, Japan

Terumo Corporation is a prominent global medical device company specializing in cardiovascular and interventional systems. The company is widely recognized for its high-quality angioplasty balloons, guidewires, and stent systems. Terumo has built a strong reputation in interventional cardiology and vascular therapy, with a focus on precision, safety, and performance. The company continues to expand its global footprint, particularly in Asia-Pacific and emerging markets, where demand for cardiovascular treatments is rising. Its innovation-driven strategy and strong presence in minimally invasive technologies make it a key player in the market.

 

• B. Braun Melsungen AG

Headquarters: Melsungen, Germany

B. Braun is a well-established global healthcare company offering a wide range of medical devices, surgical instruments, and vascular products. The company has a significant role in the angioplasty market through its interventional and infusion therapy solutions. With over 63,000 employees and operations in more than 60 countries, B. Braun provides thousands of healthcare products, many of which are manufactured in-house. The company focuses on quality manufacturing, innovation, and integrated healthcare solutions, supporting hospitals and clinicians in delivering safe and efficient patient care.

 

Are you ready to discover more about the angioplasty balloons stents market?

The report provides an in-depth analysis of the leading companies operating in the global angioplasty balloons stents market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Angioplasty Balloons Stents Market.

 

Company Profiles

• Abbott Laboratories
• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis
• Boston Scientific Corporation
• Medtronic plc
• Terumo Corporation
• B. Braun Melsungen AG
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• Lepu Medical Technology Co., Ltd.
• Cook Medical
• Meril Life Sciences Pvt. Ltd
• Others

 

Conclusion

The global angioplasty balloons stents market is witnessing robust growth, driven by rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive treatment procedures. North America currently holds the largest market share due to advanced healthcare infrastructure, high adoption of innovative technologies, and a growing burden of lifestyle related diseases. Meanwhile, Asia Pacific is expected to witness the fastest growth during the forecast period, supported by a rapidly aging population, increasing healthcare investments, and improving access to cardiovascular treatments. Leading companies in the market are focusing on research and development strategic partnerships and product innovation to strengthen their competitive position. The integration of artificial intelligence digital technologies and robotic assisted procedures is further transforming the angioplasty landscape by enhancing precision and efficiency.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter